Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
lipemia | excess lipid causing a turbid specimen | The laboratory flagged lipemia in the submitted specimen. | Objective | Drug levels - analyte, specimen and reporting |
lithium | mood stabilizer measured with a timed blood concentration | The lithium level is documented with the evening dose and morning draw times. | Objective | Drug levels - named analytes and exposure reports |
lower limit | lowest applicable value on a stated scale or interval | The numeric result includes a qualifier at the reporting lower limit. | Objective | Drug levels - analyte, specimen and reporting |
mass concentration | mass of drug per volume of specimen | The mass concentration is reported in mg/L. | Objective | Drug levels - analyte, specimen and reporting |
measured concentration | value obtained directly by assay | The measured concentration is recorded separately from the modeled estimate. | Objective | Drug levels - analyte, specimen and reporting |
methotrexate | antimetabolite with protocol-timed levels in high-dose treatment | The methotrexate result is identified by hours from the protocol-defined infusion start. | Objective | Drug levels - named analytes and exposure reports |
molar concentration | amount of substance per volume in moles or related units | The molar concentration on the report is expressed in mmol/L. | Objective | Drug levels - analyte, specimen and reporting |
mycophenolic acid | active compound measured in certain mycophenolate exposure assessments | The mycophenolic acid report distinguishes the parent analyte from its glucuronide metabolite. | Objective | Drug levels - named analytes and exposure reports |
N-acetylprocainamide | active procainamide metabolite also called NAPA | The laboratory reports N-acetylprocainamide on a separate line from the parent drug. | Objective | Drug levels - named analytes and exposure reports |
norclozapine | clozapine metabolite measured in some monitoring panels | The norclozapine result is listed with its own units. | Objective | Drug levels - named analytes and exposure reports |
nortriptyline | tricyclic antidepressant measurable in blood | The nortriptyline report gives the specimen time relative to the last dose. | Objective | Drug levels - named analytes and exposure reports |
oxcarbazepine | antiseizure agent commonly monitored through its active monohydroxy metabolite | The order names oxcarbazepine and the report identifies its measured metabolite. | Objective | Drug levels - named analytes and exposure reports |
parent-to-metabolite ratio | parent drug concentration divided by the measured metabolite concentration | The parent-to-metabolite ratio was recorded with both analytes and collection times. | Assessment | Medication response, exposure and reconciliation |
| original compound measured separately from its metabolites | The parent drug and active metabolite appear on separate report lines. | Objective | Drug levels - analyte, specimen and reporting | |
phenobarbital | barbiturate whose blood concentration may be monitored | The phenobarbital sample time is recorded after the most recent administration. | Objective | Drug levels - named analytes and exposure reports |
phenytoin | antiseizure medicine measured as free or total drug | The phenytoin result on the original report is explicitly labeled total. | Objective | Drug levels - named analytes and exposure reports |
posaconazole | azole antifungal whose formulation and timing matter for concentration review | The posaconazole report is filed with the formulation recorded in pharmacy history. | Objective | Drug levels - named analytes and exposure reports |
primidone | antiseizure medicine assessed separately from its phenobarbital metabolite | The laboratory reports both primidone and phenobarbital. | Objective | Drug levels - named analytes and exposure reports |
procainamide | antiarrhythmic whose active metabolite may also be measured | The procainamide and metabolite concentrations are shown separately. | Objective | Drug levels - named analytes and exposure reports |
protein-bound fraction | portion of drug attached to circulating proteins | The specialist report distinguishes the protein-bound fraction from the unbound portion. | Objective | Drug levels - analyte, specimen and reporting |
quantitation limit | boundary for reliable numerical measurement | The laboratory reported the value as below its lower quantitation limit. | Objective | Drug levels - analyte, specimen and reporting |
reportable range | interval over which the laboratory reports a validated measurement | The result exceeds the upper end of the assay's reportable range. | Objective | Drug levels - analyte, specimen and reporting |
sample integrity | condition of the specimen on receipt | The laboratory noted a sample integrity concern on arrival. | Objective | Drug levels - analyte, specimen and reporting |
serum level | concentration measured in serum | The serum level is reported in ng/mL on the original result. | Objective | Drug levels - analyte, specimen and reporting |
sirolimus | mTOR inhibitor monitored using whole-blood concentrations in specified settings | The sirolimus report states whole blood and the collection time. | Objective | Drug levels - named analytes and exposure reports |